Emeka Egwim, a federal government HIV/AIDS policy specialist who also has served in the Medicaid Drug Rebate Program, is the new head of the federal 340B Drug Pricing Program.
In a letter this morning to its staff, the U.S. Health Resources and Services Administration (HRSA) announced Egwim’s selection as the Director of the Office of Pharmacy Affairs (OPA) within the Office of Special Health Initiatives (OSHI) in HRSA. OSHI Director Krista Pedley made the announcement. Pedley, a U.S. assistant surgeon general and U.S. Public Health Service rear admiral, ran OPA from July 2010 to January 2021 when she was tapped to head OSHI. Pedley’s long-time civil service deputy at OPA, Michelle Herzog, has been leading the 340B program on an acting basis. Pedley’s letter says Herzog will resume her role as OPA’s deputy director.
Emeka Egwim, a federal government HIV/AIDS policy specialist who also has served in the Medicaid Drug Rebate Program, is the new head of the federal 340B Drug Pricing Program.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
